Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Advertisement
TMED
US Health Care
Active

T. Rowe Price Health Care ETF

This ETF provides exposure to Other US Health Care Equities

TMED performance and flow charts

Last update 9/9/2026 at 1:30 PM
Live
Closed
Last price
$34.39
-$0.48 (-1.38%) Yesterday

Performance

-1.00.01.02.03.04.0%Aug 10Aug 17Aug 25Sep 1Sep 8

Flows

0 M1 M2 M3 M4 M
1 day price range
$34.39
$34.77
52 week price range
$25.58
$36.68
1W perf
-1.58%
YTD perf
+17.46%
YTD flows
+$13M
AuM
$33M
E/R
0.44%
TTM yield
0.46%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 8, 2026
1M3MYTD1Y3Y5Y
Perf.-1.44%+11.05%+17.46%+35.43%
Flows+$4M+$10M+$13M+$15M--
Data as of September 8, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderT. Rowe Price
N° of holdings97
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 11, 2025
ESGNo
TrackinsightTrackinsight

More data and info about TMED on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

61.11%

Total weight of top 15 holdings out of 97

Top 15 Holdings

Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.3%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.6%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.2%
McKesson Corp.
1.72%

Sectors

Healthcare
98.58%
Other
1.42%

Countries

USA
93.59%
Other
6.41%
Advertisement

Trading data

Last sale
9/9/2026 at 1:30 PM
$34.39
Previous close
$34.87
Consolidated volume
09/09/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+18.14%+18.39%
Max drawdown
-4.97%-11.09%
Max drawdown duration
20d125dN/AN/A
Time to recover
N/A62dN/AN/A
Advertisement
Frequently asked questions about TMED

What type of ETF is TMED?

TMED is a Active ETF that provides exposure to Equity assets. It is managed by T. Rowe Price.

What does TMED invest in?

This ETF provides exposure to Other US Health Care Equities. It is part of the segment: US Health Care.

What is the expense ratio of TMED?

The total expense ratio (TER) of TMED is 0.44%, representing the annual fee charged by the fund manager.

When was TMED launched?

TMED was launched on June 11, 2025, marking its entry into the ETF market.

Who is the issuer of TMED?

TMED is issued by T. Rowe Price.

What is the AUM of TMED?

As of September 8, 2026, TMED manages $33.12 M, reflecting the total assets held in the fund.

How has TMED performed recently?

As of September 8, 2026, TMED delivered a return of -1.44% over the past month (1M performance), 11.05% over the past three months (3M), and 17.46% year-to-date (YTD).

What are the recent fund flows for TMED?

As of September 8, 2026, TMED has seen net flows of +$4M in the past month (1M flow) and +$13M year-to-date (YTD).

Does TMED pay dividends?

As of September 8, 2026, TMED has a trailing 12-month distribution yield of 0.46%.

How many holdings are in TMED

As of July 31, 2026, TMED holds 97 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is TMED?

As of July 31, 2026, TMED holds 97 securities, with 61.11% of its assets concentrated in its top 15 holdings.

What are the top holdings of TMED?

As of July 31, 2026, TMED holds a portfolio of 97 underlyings, with its largest positions including Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does TMED invest in?

As of July 31, 2026, TMED has its largest geographic exposures in USA.

What sectors or themes does TMED focus on?

As of July 31, 2026, TMED is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up